DK1926483T3 - Behandling af autoimmune sygdomme - Google Patents
Behandling af autoimmune sygdommeInfo
- Publication number
- DK1926483T3 DK1926483T3 DK06793341.6T DK06793341T DK1926483T3 DK 1926483 T3 DK1926483 T3 DK 1926483T3 DK 06793341 T DK06793341 T DK 06793341T DK 1926483 T3 DK1926483 T3 DK 1926483T3
- Authority
- DK
- Denmark
- Prior art keywords
- autoimmune diseases
- treatment
- neuritis
- uveitis
- invention describes
- Prior art date
Links
- 208000023275 Autoimmune disease Diseases 0.000 title abstract 2
- 206010029240 Neuritis Diseases 0.000 abstract 2
- 206010046851 Uveitis Diseases 0.000 abstract 1
- 150000001414 amino alcohols Chemical class 0.000 abstract 1
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 abstract 1
- 201000006417 multiple sclerosis Diseases 0.000 abstract 1
- 201000001119 neuropathy Diseases 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 125000002467 phosphate group Chemical class [H]OP(=O)(O[H])O[*] 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Physical Education & Sports Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US71599005P | 2005-09-09 | 2005-09-09 | |
PCT/EP2006/066150 WO2007028821A2 (en) | 2005-09-09 | 2006-09-07 | Treatment of autoimmune diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1926483T3 true DK1926483T3 (da) | 2011-03-14 |
Family
ID=37056992
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10174280.7T DK2295049T3 (da) | 2005-09-09 | 2006-09-07 | Behandling af autoimmunsygdomme |
DK06793341.6T DK1926483T3 (da) | 2005-09-09 | 2006-09-07 | Behandling af autoimmune sygdomme |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK10174280.7T DK2295049T3 (da) | 2005-09-09 | 2006-09-07 | Behandling af autoimmunsygdomme |
Country Status (29)
Country | Link |
---|---|
US (1) | US20080200438A1 (da) |
EP (2) | EP1926483B1 (da) |
JP (4) | JP5244598B2 (da) |
KR (3) | KR20140117704A (da) |
CN (1) | CN101257899B (da) |
AT (1) | ATE489948T1 (da) |
AU (2) | AU2006289100B2 (da) |
BR (1) | BRPI0615906A2 (da) |
CA (2) | CA2620554C (da) |
CY (1) | CY1111285T1 (da) |
DE (1) | DE602006018629D1 (da) |
DK (2) | DK2295049T3 (da) |
ES (2) | ES2529724T3 (da) |
HK (1) | HK1149906A1 (da) |
IL (2) | IL189665A (da) |
JO (1) | JO2655B1 (da) |
MA (1) | MA29787B1 (da) |
MX (1) | MX2008003170A (da) |
NO (1) | NO20081727L (da) |
NZ (2) | NZ566137A (da) |
PL (2) | PL2295049T3 (da) |
PT (2) | PT1926483E (da) |
RU (2) | RU2493840C2 (da) |
SG (1) | SG165364A1 (da) |
SI (2) | SI1926483T1 (da) |
TN (1) | TNSN08103A1 (da) |
TW (2) | TWI372620B (da) |
WO (1) | WO2007028821A2 (da) |
ZA (1) | ZA200801694B (da) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101178318B1 (ko) * | 2004-07-16 | 2012-08-29 | 교린 세이야꾸 가부시키 가이샤 | 효과적인 의약의 사용법 및 부작용 발현의 방어에 관한방법 |
EP1806338B1 (en) | 2004-10-12 | 2016-01-20 | Kyorin Pharmaceutical Co., Ltd. | Process for producing 2-amino-2-[2-[4-(3-benzyloxy-phenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride and hydrates thereof. and intermediates the production thereof |
AU2006300485B2 (en) * | 2005-10-07 | 2011-08-25 | Kyorin Pharmaceutical Co., Ltd. | Therapeutic agent for liver disease containing 2-amino-1,3-propanediol derivative as active ingredient and therapeutic method for liver disease |
TWI389683B (zh) * | 2006-02-06 | 2013-03-21 | Kyorin Seiyaku Kk | A therapeutic agent for an inflammatory bowel disease or an inflammatory bowel disease treatment using a 2-amino-1,3-propanediol derivative as an active ingredient |
NZ574012A (en) * | 2006-08-08 | 2012-02-24 | Kyorin Seiyaku Kk | Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
US8232319B2 (en) * | 2006-08-08 | 2012-07-31 | Kyorin Pharmaceutical Co., Ltd. | Amino phosphate derivative and S1P receptor modulator having same as an active ingredient |
JP5198293B2 (ja) * | 2007-02-13 | 2013-05-15 | 杏林製薬株式会社 | アミノアルコール誘導体を有効成分とする脱髄性疾患の治療剤又は予防剤 |
WO2009099174A1 (ja) | 2008-02-07 | 2009-08-13 | Kyorin Pharmaceutical Co., Ltd. | アミノアルコール誘導体を有効成分とする炎症性腸疾患の治療剤又は予防剤 |
JPWO2009142195A1 (ja) * | 2008-05-20 | 2011-09-29 | 杏林製薬株式会社 | 寛解導入維持剤 |
MX2011001881A (es) * | 2008-08-18 | 2011-05-30 | Novartis Ag | Derivados de amino-alcohol para el tratamiento de neuropatias perifericas desmielinizantes. |
MA34285B1 (fr) * | 2010-05-06 | 2013-06-01 | Novartis Ag | Traitement de maladies autoimmunes |
WO2011138398A1 (en) * | 2010-05-06 | 2011-11-10 | Novartis Ag | Dosage regimen of diaryl sulfide derivatives |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5141421A (en) * | 1991-12-17 | 1992-08-25 | Carrier Corporation | Nested coupling mechanism for scroll machines |
DE4428835A1 (de) * | 1994-08-01 | 1996-02-08 | Schering Ag | Neue 3-substituierte 3H-2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel |
CA2282378C (en) * | 1997-02-27 | 2008-12-30 | Yoshitomi Pharmaceutical Industries Ltd. | Pharmaceutical composition |
US6960692B2 (en) * | 2001-09-27 | 2005-11-01 | Kyorin Pharmaceutical Co., Ltd. | Diaryl sulfide derivative, addition salt thereof, and immunosuppressant |
WO2003029184A1 (fr) | 2001-09-27 | 2003-04-10 | Kyorin Pharmaceutical Co., Ltd. | Derive d'ether de diaryle, son sel d'addition et son immunosuppresseur |
BR0314455A (pt) * | 2002-09-19 | 2005-07-26 | Kyorin Seiyaku Kk | Derivados de aminoálcool, seus sais e agentes imunosupressores |
KR20050054958A (ko) * | 2002-09-24 | 2005-06-10 | 노파르티스 아게 | 탈수초성 장애의 치료에 있어서의 스핑고신-1-포스페이트수용체 아고니스트 |
CA2499882C (en) * | 2002-09-28 | 2010-11-09 | Mcneil-Ppc, Inc. | Modified release dosage form with two cores |
CN100344638C (zh) * | 2003-02-18 | 2007-10-24 | 杏林制药株式会社 | 氨基膦酸衍生物、其加成盐以及s1p受体调节剂 |
KR20050121712A (ko) * | 2003-04-08 | 2005-12-27 | 노파르티스 아게 | 유기 화합물 |
TW200505416A (en) * | 2003-08-12 | 2005-02-16 | Mitsubishi Pharma Corp | Bi-aryl compound having immunosuppressive activity |
CA2535704C (en) * | 2003-08-28 | 2012-12-11 | Novartis Ag | Aminopropanol derivatives |
KR101178318B1 (ko) * | 2004-07-16 | 2012-08-29 | 교린 세이야꾸 가부시키 가이샤 | 효과적인 의약의 사용법 및 부작용 발현의 방어에 관한방법 |
RU2478384C2 (ru) * | 2004-11-29 | 2013-04-10 | Новартис Аг | Курс лечения с использованием агониста рецептора s1p |
GB0504544D0 (en) * | 2005-03-04 | 2005-04-13 | Novartis Ag | Organic compounds |
-
2006
- 2006-09-07 RU RU2011111117/15A patent/RU2493840C2/ru not_active IP Right Cessation
- 2006-09-07 BR BRPI0615906-0A patent/BRPI0615906A2/pt not_active IP Right Cessation
- 2006-09-07 KR KR1020147026128A patent/KR20140117704A/ko not_active Application Discontinuation
- 2006-09-07 CN CN2006800328984A patent/CN101257899B/zh not_active Expired - Fee Related
- 2006-09-07 US US12/065,096 patent/US20080200438A1/en not_active Abandoned
- 2006-09-07 MX MX2008003170A patent/MX2008003170A/es active IP Right Grant
- 2006-09-07 SG SG201006580-3A patent/SG165364A1/en unknown
- 2006-09-07 KR KR1020147001496A patent/KR101476591B1/ko not_active IP Right Cessation
- 2006-09-07 ES ES10174280.7T patent/ES2529724T3/es active Active
- 2006-09-07 ES ES06793341T patent/ES2357426T3/es active Active
- 2006-09-07 AU AU2006289100A patent/AU2006289100B2/en not_active Ceased
- 2006-09-07 DK DK10174280.7T patent/DK2295049T3/da active
- 2006-09-07 CA CA2620554A patent/CA2620554C/en not_active Expired - Fee Related
- 2006-09-07 JO JO2006298A patent/JO2655B1/en active
- 2006-09-07 AT AT06793341T patent/ATE489948T1/de active
- 2006-09-07 SI SI200630937T patent/SI1926483T1/sl unknown
- 2006-09-07 JP JP2008529636A patent/JP5244598B2/ja active Active
- 2006-09-07 DE DE602006018629T patent/DE602006018629D1/de active Active
- 2006-09-07 DK DK06793341.6T patent/DK1926483T3/da active
- 2006-09-07 PT PT06793341T patent/PT1926483E/pt unknown
- 2006-09-07 CA CA2820510A patent/CA2820510A1/en not_active Abandoned
- 2006-09-07 RU RU2008113187/15A patent/RU2424795C2/ru not_active IP Right Cessation
- 2006-09-07 NZ NZ566137A patent/NZ566137A/en not_active IP Right Cessation
- 2006-09-07 WO PCT/EP2006/066150 patent/WO2007028821A2/en active Application Filing
- 2006-09-07 PL PL10174280T patent/PL2295049T3/pl unknown
- 2006-09-07 PT PT10174280T patent/PT2295049E/pt unknown
- 2006-09-07 PL PL06793341T patent/PL1926483T3/pl unknown
- 2006-09-07 EP EP06793341A patent/EP1926483B1/en active Active
- 2006-09-07 NZ NZ588372A patent/NZ588372A/en not_active IP Right Cessation
- 2006-09-07 EP EP10174280.7A patent/EP2295049B1/en active Active
- 2006-09-07 SI SI200631889T patent/SI2295049T1/sl unknown
- 2006-09-08 TW TW099117063A patent/TWI372620B/zh not_active IP Right Cessation
- 2006-09-08 TW TW095133326A patent/TWI376223B/zh active
-
2008
- 2008-02-21 ZA ZA200801694A patent/ZA200801694B/xx unknown
- 2008-02-21 IL IL189665A patent/IL189665A/en not_active IP Right Cessation
- 2008-03-06 TN TNP2008000103A patent/TNSN08103A1/en unknown
- 2008-03-17 MA MA30758A patent/MA29787B1/fr unknown
- 2008-04-07 NO NO20081727A patent/NO20081727L/no not_active Application Discontinuation
- 2008-04-08 KR KR1020087008413A patent/KR101476451B1/ko not_active IP Right Cessation
-
2010
- 2010-09-21 AU AU2010224355A patent/AU2010224355B2/en not_active Ceased
-
2011
- 2011-03-01 CY CY20111100242T patent/CY1111285T1/el unknown
- 2011-04-27 HK HK11104200A patent/HK1149906A1/xx unknown
-
2012
- 2012-10-17 JP JP2012230044A patent/JP6077265B2/ja not_active Expired - Fee Related
-
2014
- 2014-06-23 IL IL233328A patent/IL233328A0/en unknown
- 2014-09-29 JP JP2014199069A patent/JP2015025002A/ja not_active Withdrawn
-
2016
- 2016-09-30 JP JP2016193400A patent/JP2017019854A/ja not_active Withdrawn
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1926483T3 (da) | Behandling af autoimmune sygdomme | |
TW200509892A (en) | Novel aminobenzophenone compounds | |
ATE478863T1 (de) | Heterotetracyclische verbindungen als tpo- mimetica | |
EA200801362A1 (ru) | Пиримидинил бензотиофеновые соединения | |
EP1841426A4 (en) | TERTIARY CARBINAMINES INCLUDING SUBSTITUTED HETEROCYCLES AS BETA SECRETASE INHIBITORS AND FOR THE TREATMENT OF ALZHEIMER'S DISEASE | |
EA201071243A1 (ru) | Комбинированные композиции для лечения болезни альцгеймера и родственных заболеваний зонизамидом и акампросатом | |
TW200631583A (en) | Substituted pteridines for the treatment of inflammatory diseases | |
DK1776349T3 (da) | 2-amino-puinazolin derivater anvendelige som inhibitorer af beta-sekretase (BACE) | |
EA201070247A1 (ru) | Ингибиторы протеасом | |
EA200970575A1 (ru) | Соединения на основе 4-фенил-6-(2,2,2-трифтор-1-фенилэтокси)пиримидина и способы их применения | |
DK1789398T3 (da) | 2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE) | |
NO20072092L (no) | Sulfonamidforbindelser | |
EA200802054A1 (ru) | Ингибиторы фермента | |
UA90698C2 (en) | Triazole substituted aminobenzophenone compounds | |
EA201000494A1 (ru) | Новые гидрокси-8-гетероарилфенантридины и их применение в качестве ингибиторов pde4 | |
WO2006078576A3 (en) | Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease | |
MX2011012015A (es) | Tratamiento de deterioro cognitivo leve y enfermedad de alzheimer. | |
EA201170344A1 (ru) | Азаиндольные ингибиторы iap | |
TW200639155A (en) | Thiazolidinones, their production and use as pharmaceutical agents | |
MX2010000956A (es) | Derivados de isoftalamida que inhiben actividad de beta-secretasa. | |
EA200702336A1 (ru) | ПРИМЕНЕНИЕ 24-норУДХК | |
BRPI0512732A (pt) | formulações tópicas para tratamento de doenças alérgicas | |
EA200701815A1 (ru) | 6-гетероарил-1,2,3,4,4а,10в-гексагидрофенантридины в качестве pde-4 ингибиторов для лечения воспалительных заболеваний | |
EA200600115A1 (ru) | Производные 2-аминобензойной кислоты | |
WO2009051661A3 (en) | Substituted aryl alkylamino-oxy-analogs and uses thereof |